Living DonorsUnrelated DonorsTissue DonorsTransplantation, HomologousKidney TransplantationLiver TransplantationHematopoietic Stem Cell TransplantationBone Marrow TransplantationHistocompatibility TestingDirected Tissue DonationTransplantation ConditioningGraft SurvivalHistocompatibilityGraft vs Host DiseaseTissue and Organ ProcurementSiblingsGraft RejectionHematologic NeoplasmsCadaverTreatment OutcomeHeart TransplantationTransplantation, AutologousLung TransplantationHLA AntigensImmunosuppressive AgentsStem Cell TransplantationRetrospective StudiesOrgan TransplantationSurvival AnalysisRecurrenceBlood DonorsSurvival RatePancreas TransplantationTime FactorsIslets of Langerhans TransplantationTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraTransplantation, IsogeneicTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationTransplantation ToleranceLiver FailurePeripheral Blood Stem Cell TransplantationImmunosuppressionSkin TransplantationFetal Tissue TransplantationPostoperative ComplicationsWaiting ListsCorneal TransplantationTransplantation, HeterologousMesenchymal Stem Cell TransplantationWhole-Body IrradiationTacrolimusTissue TransplantationCyclosporineFollow-Up StudiesOrgan PreservationTissue and Organ HarvestingTransplantsLiver DiseasesBrain Tissue TransplantationFacial TransplantationBrain DeathDonor SelectionBusulfanLeukemiaKidney Failure, ChronicRisk FactorsAntilymphocyte SerumBlood Group IncompatibilityMice, Inbred C57BLAnemia, AplasticBronchiolitis ObliteransCytomegalovirus InfectionsCombined Modality TherapyAcute DiseaseHematopoietic Stem CellsLiverPostoperative PeriodRemission InductionRats, Inbred LewMycophenolic AcidT-LymphocytesDelayed Graft FunctionHand TransplantationEnd Stage Liver DiseasePatient SelectionPrognosisCyclophosphamideMyeloablative AgonistsABO Blood-Group SystemProspective StudiesDisease-Free SurvivalPrimary Graft DysfunctionChimerismCold IschemiaLymphocyte Depletion